Longport Inc is a premier provider of advanced, high resolution imaging systems that enhance the prevention, assessment, and treatment of medical conditions. Founded in 1993, Longport has been focused on high resolution medical ultrasound since 1999. Their technology offers high resolution medical ultrasound imaging for use in dermatology, non-invasive wound assessment, pressure ulcer prevention, assessment of skin cancers, burns, and deep tissue injuries.

Longport's Episcan I-200 is a high frequency ultrasound imaging system that provides clear and detailed images, setting it apart from other mainstream ultrasound systems. It can be utilized in various applications such as dermatology, aesthetics, wound assessment, and research. Longport's mission is to make a significant impact on the $45 billion skin diseases market and the $10 billion aesthetic procedures market in the USA.

With their advanced technology, Longport aims to improve patient outcomes and revolutionize the field of medical imaging